Michael Miller to Cross-Sectional Studies
This is a "connection" page, showing publications Michael Miller has written about Cross-Sectional Studies.
Connection Strength
0.822
-
Patient and Health Care Professional Perspectives About Referral, Self-Reported Use, and Perceived Importance of Digital Mental Health App Attributes in a Diverse Integrated Health System: Cross-Sectional Survey Study. JMIR Form Res. 2024 Nov 15; 8:e59831.
Score: 0.179
-
Patient experience after modifying visit delivery during the COVID-19 pandemic. Am J Manag Care. 2021 02 01; 27(2):e54-e63.
Score: 0.138
-
Depression screening for prescribed medications with mental health risk: Considerations for clinical decision support, workflow redesign, and health information exchange arrangements. Res Social Adm Pharm. 2017 May - Jun; 13(3):485-493.
Score: 0.100
-
A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned. J Eval Clin Pract. 2014 Oct; 20(5):638-48.
Score: 0.087
-
Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care. Ann Pharmacother. 2013 Jun; 47(6):797-804.
Score: 0.081
-
Using single-item health literacy screening questions to identify patients who read written nonsteroidal anti-inflammatory medicine information provided at pharmacies. J Health Commun. 2010 Jun; 15(4):413-27.
Score: 0.066
-
The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Ann Pharmacother. 2010 Feb; 44(2):274-84.
Score: 0.064
-
Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge. J Patient Saf. 2017 Dec; 13(4):217-222.
Score: 0.028
-
Socio-demographic differences in risk information seeking sources for non-steroidal anti-inflammatory drugs (NSAIDS). Int J Med Inform. 2016 10; 94:222-7.
Score: 0.025
-
Risk of major morbidity and death in older adults with suicidal intent: a cross-sectional analysis from the National Poison Data System, 2000-2009. J Am Geriatr Soc. 2015 Mar; 63(3):501-7.
Score: 0.023
-
Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness. Patient Educ Couns. 2011 Jun; 83(3):391-7.
Score: 0.017
-
Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007. J Am Pharm Assoc (2003). 2009 Sep-Oct; 49(5):e110-7.
Score: 0.016